College of Medical, Veterinary & Life Sciences

Patient & Public Involvement (PPI) 

We define Patient and Public Involvement (PPI) as research carried out with the active involvement of patients, carers, members of the public and other stakeholders, rather than research done to them or for them. These PPI partners contribute across the research lifecycle, from shaping study design to supporting the dissemination of results.

Our team helps researchers embed meaningful PPI from the grant application stage through to project delivery. Support is available to all University and NHS researchers, including those in basic or discovery science.A core part of our work is our collaboration with a well‑established PPI Steering Group, whose insight informs MVLS PPI priorities. We also work with a specialist PPI Group focused on medical technology, including devices, health apps and large data projects. We can:
  • facilitate access to lay perspectives on research proposals and ethics applications
  • support planning and costing of PPI activities
  • signpost researchers to external networks and organisations that can connect them with experienced PPI partners

 

 

MVLS Patient & Public Involvement Strategy

PPI-Strategy-2025-2027-v1.1.pdf

The MVLS Patient and Public Involvement (PPI) Strategy (2025–2027) provides a clear plan for strengthening public involvement across all health research. Co‑developed with patient and public partners, university staff, and NHS colleagues the strategy seeks to ensure that public perspectives shape every stage of research. The strategy aims to build an inclusive culture where public contributors play a central role. It focuses on three main priorities visibility, capacity and training, which are key to growing and sustaining PPI across MVLS.

 

People connecting icon

For Researchers

Square people icon

For Public

Together for Health Research

PPIE at Digital Health Validation Lab

  • Gaining insights from both patients and clinicians is key to enhancing the usability and acceptability of digital health products. 
  • DHVL ensures that patient and public voices are integrated into trial design and product development through carefully planned PPIE activities, aligning with early-stage requirements set by many funders and healthcare decision-makers.

Contact us

MVLS PPIE Group

University of Glasgow
Level 5, Clarice Pears Building
90 Byres Road
Glasgow
G12 8TB

mvls-ppie@gla.systa-s.com